Biolife solutions appoints cell therapy executive timothy l. moore to its board of directors

Industry veteran brings extensive technical operations scale-up experience and extreme fluency in cell therapy tools and services selection process bothell, wash. , aug. 25, 2022 /prnewswire/ --  biolife solutions, inc. (nasdaq: blfs) ("biolife" or the "company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies ("cgt") and the broader biopharma markets, today announced the appointment of timothy l.
BLFS Ratings Summary
BLFS Quant Ranking